









Markets
/
Stocks
/
nasdaq-mgrx
/

Mangoceuticals Inc

MGRX

0.713USD

-0.597-45.57%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

9.90MMarket Cap

0.01P/E TTM



Mangoceuticals Inc

0.713

-0.597-45.57%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Mangoceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-6.47%-1.24M

20.34%-1.26M

-129.51%-2.27M

33.47%-1.13M

31.85%-1.17M

11.34%-1.58M

45.24%-991.13K

-161.37%-1.70M

-184.96%-1.71M

---1.78M

---1.81M

---649.56K

---600.35K

Net income from continuing operations

-281.00%-7.62M

-126.48%-5.42M

-104.40%-4.84M

24.12%-1.95M

-11.13%-2.00M

-4.70%-2.39M

7.55%-2.37M

-281.21%-2.57M

-84.50%-1.80M

---2.28M

---2.56M

---673.65K

---975.32K

Operating gains losses

113000.79%285.01K

25991.54%836.23K

6567.61%414.99K

11373.34%721.79K

-95.99%252.00

-48.51%3.21K

2.33%6.22K

62.85%6.29K

--6.29K

--6.22K

--6.08K

--3.86K

----

Other non-cash items

672.12%5.41M

207.94%3.18M

365.43%1.94M

-106.49%-23.29K

726.53%700.48K

166.43%1.03M

-40.50%416.50K

452.71%358.90K

-68.02%84.75K

--387.00K

--700.00K

---101.76K

--265.00K

Change in working capital

-1806.34%-415.83K

133.52%97.07K

-82.50%160.24K

-8.53%69.55K

135.23%24.37K

-619.48%-289.57K

4441.71%915.80K

35.98%76.03K

-11.48%-69.17K

--55.74K

---21.09K

--55.92K

---62.05K

-Change in inventory

----

-271.69%-5.29K

-57.87%806.00

101.84%433.00

--4.05K

--3.08K

--1.91K

---23.49K

----

-Change in prepaid expenses

-851.94%-100.00K

77.99%83.21K

-9325.50%-83.21K

-100.00%0.00

142.06%13.30K

317.60%46.75K

104.62%902.00

-9.80%23.43K

16.17%-31.62K

---21.48K

---19.53K

--25.98K

---37.72K

-Change in payables and accrued expense

-883.46%-276.66K

127.03%89.82K

-62.57%340.68K

61.57%83.54K

185.82%35.31K

-434.27%-332.30K

31714.45%910.18K

--51.71K

---41.15K

--99.41K

---2.88K

----

-Change in other current assets

9.01%16.46K

8.95%16.10K

8.63%15.72K

8.81%15.42K

10.00%15.10K

7.44%14.78K

8.59%14.47K

107.41%14.17K

--13.73K

--13.76K

--13.32K

---191.18K

----

-Change in other current liabilities

68.11%-7.69K

-2871.30%-104.47K

-6051.31%-95.70K

-372.27%-7.58K

-1261.78%-24.11K

-306.70%-3.52K

-5.80%1.61K

-178.45%-1.60K

209.24%2.08K

--1.70K

--1.71K

--2.05K

--671.00

Cash from non-recurring investing activities

Cash from operating activities

-6.47%-1.24M

20.34%-1.26M

-129.51%-2.27M

33.47%-1.13M

31.85%-1.17M

11.34%-1.58M

45.24%-991.13K

-161.37%-1.70M

-184.96%-1.71M

---1.78M

---1.81M

---649.56K

---600.35K

Investing cash flow

Net cash from continuing investing activities

----

--0.00

---65.00K

-100.00%0.00

--0.00

--3.52K

--40.57K

--2.53K

Capital expenditures

----

-100.00%0.00

--0.00

--3.52K

--40.57K

--2.53K

Net cash flow from disposal of fixed assets

----

--0.00

---65.00K

-100.00%0.00

--0.00

--3.52K

--40.57K

--2.53K

Cash from non-current investing activities

Net cash flow from investing activities

----

--0.00

--65.00K

100.00%0.00

--0.00

---3.52K

---40.57K

---2.53K

Financing cash flow

Cash flow from continuous financing activities

116.21%1.62M

-35.58%1.28M

754.21%2.29M

-6.46%1.12M

--750.00K

112.58%1.99M

-94.56%267.50K

140.24%1.20M

-100.00%0.00

--935.30K

--4.92M

--499.50K

--1.48M

Net cash flow from debt Issuance/repayment

--0.00

500.00%600.00K

----

---37.50K

--0.00

212.11%100.00K

211.81%87.50K

--0.00

100.00%0.00

---89.20K

---78.26K

--0.00

---13.39K

Net cash flow from common stock issuance/repurchase

--1.32M

10.95%430.79K

263.89%655.00K

-36.67%760.00K

--0.00

--388.27K

-96.40%180.00K

140.24%1.20M

-100.00%0.00

--0.00

--5.00M

--499.50K

--1.50M

Net cash flow from preferred stock issuance/repurchase

-100.00%0.00

-170.00%-1.05M

--1.15M

--400.00K

--750.00K

--1.50M

----

Proceeds from issuance of warrants

---853.00K

--1.30M

--480.00K

----

--0.00

--1.02M

----

Net cash flow from other financing activities

--1.15M

----

---11.61K

Net cash from non-recurrent financing activities

Net cash from financing activities

116.21%1.62M

-35.58%1.28M

754.21%2.29M

-6.46%1.12M

--750.00K

112.58%1.99M

-94.56%267.50K

140.24%1.20M

-100.00%0.00

--935.30K

--4.92M

--499.50K

--1.48M

Net cash flow

Beginning cash balance

-79.39%101.02K

399.81%76.50K

-92.06%58.65K

-94.02%73.91K

-83.37%490.24K

-99.60%15.30K

8.22%739.01K

--1.24M

--2.95M

--3.79M

--682.86K

--0.00

Current period cash flow changes

191.34%380.26K

-94.84%24.52K

102.47%17.84K

96.93%-15.26K

75.66%-416.33K

156.29%474.94K

-123.28%-723.70K

-161.10%-497.74K

-296.05%-1.71M

---843.72K

--3.11M

---190.63K

--872.62K

Effect of exchange rate changes

90.95%-45.00

117.06%187.00

10991.43%7.62K

---8.18K

---497.00

---1.10K

---70.00

----

Ending cash balance

551.15%481.28K

-79.39%101.02K

399.81%76.50K

-92.06%58.65K

-94.02%73.91K

-83.37%490.24K

-99.60%15.30K

487.66%739.01K

41.73%1.24M

--2.95M

--3.79M

---190.63K

--872.62K

Free cash flow

----

33.47%-1.13M

31.85%-1.17M

11.34%-1.58M

45.34%-991.13K

-146.00%-1.70M

-183.76%-1.71M

---1.78M

---1.81M

---690.13K

---602.88K

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

